NCT00345904View on ClinicalTrials.gov

Study to Evaluate the Safety and Immunogenicity of Fluarix™ 2006/2007 in Adults Aged 18 Years or Above

PHASE3CompletedINTERVENTIONAL

Enrollment

120

Participants

Timeline

Start Date

July 31, 2006

Study Completion Date

August 31, 2006

Conditions

Influenza

Interventions

BIOLOGICAL

Fluarix

Trial Locations (4)

01097

GSK Investigational Site, Dresden

01099

GSK Investigational Site, Dresden

01277

GSK Investigational Site, Dresden

01705

GSK Investigational Site, Freital

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY

NCT00345904 - Study to Evaluate the Safety and Immunogenicity of Fluarix™ 2006/2007 in Adults Aged 18 Years or Above | Biotech Hunter | Biotech Hunter